Continuous subcutaneous apomorphine infusion in the early phase of advanced Parkinson’s disease: A prospective study of 22 patients

INTRODUCTION: Parkinson’s disease (PD) patients usually start treatment with apomorphine infusion (APO) in later stages of advanced PD (aPD). This timing limits the evaluation of its motor efficacy and other potential clinical benefits throughout the full course of aPD. METHODS: We prospectively ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Pajarín, Gustavo, Sesar, Ángel, Jiménez Martín, Isabel, Ares, Begoña, Castro, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718975/
https://www.ncbi.nlm.nih.gov/pubmed/35005605
http://dx.doi.org/10.1016/j.prdoa.2021.100129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718975/
https://www.ncbi.nlm.nih.gov/pubmed/35005605
http://dx.doi.org/10.1016/j.prdoa.2021.100129

Ejemplares similares